DrugPatentWatch Database Preview
« Back to Dashboard
Summary for Patent: 4,971,998
|Title:||Methods for treating the premenstrual or late luteal phase syndrome|
|Abstract:||Compositions useful in the treatment of disturbances of appetite, disturbances of mood, or both, associated with premenstrual syndrome, as well as methods of use therefor. The compositions include serotoninergic drugs, such as d-fenfluramine and fluoxetine.|
|Inventor(s):||Wurtman; Richard J. (Boston, MA), Wurtman; Judith J. (Boston, MA)|
|Assignee:||Massachusetts Institute of Technology (Cambridge, MA)|
|Patent Litigation and PTAB cases:||See patent lawsuits and PTAB cases for patent 4,971,998|
1. A method for treating disturbances of mood, disturbances of appetite, or both, associated with premenstrual syndrome, comprising administering to a woman prior to onset of
her menstrual period approximately 7 mg to approximately 60 mg per day of d-fenfluramine or or d, 1-fenfluramine.
2. A method for treating disturbances of mood, disturbances of appetite, or both, associated with pre-menstrual syndrome, comprising administering to a woman prior to the onset of her menstrual period, a composition consisting essentially of approximately 5 mg to approximately 120 mg of fluoxetine.
3. A method of treating depressed mood, carbohydrate craving or both associated with premenstrual syndrome, comprising administering to a woman, prior to onset of her menstrual period and on alternate days, from approximately 5 mg to approximately 120 mg of fluoxetine.
4. A method for treating negative mood states associated with premenstrual syndrome, comprising administering daily to a woman, prior to onset of her menstrual period, approximately 7 mg to approximately 60 mg of d-fenfluramine or d, 1-fenfluramine.
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.